Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy

Developmental Medicine and Child Neurology

Volumn 53, Issue 2, 2011, Pages 125-130

  O'flaherty, Stephen J ^a   Janakan, Vyshnavi ^a   Morrow, Angela M ^a   Scheinberg, Adam M ^a,b   Waugh, Mary Clare A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CEREBRAL PALSY; CHILD; DRUG EFFECT; DYSPHAGIA; FEMALE; FLU LIKE SYNDROME; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HEALTH STATUS; HUMAN; INCONTINENCE; INJECTION SITE CONTUSION; INJECTION SITE PAIN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORBIDITY; MORTALITY; NAUSEA AND VOMITING; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY ASPIRATION; SCHOOL CHILD; SEIZURE; SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URINARY FREQUENCY; WEAKNESS;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DEGLUTITION DISORDERS; DISABILITY EVALUATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FECAL INCONTINENCE; FEMALE; HEALTH STATUS; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; NEW SOUTH WALES; REGURGITATION, GASTRIC; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; URINARY INCONTINENCE;

EID: 78751530119     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03814.x     Document Type: Article

References (28)

1. Koman LA, Mooney JF III, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994; 14: 299-303.
2. Goldstein EM. Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol 2006; 21: 189-92.
3. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997; 39: 185-93.
4. Molenaers G, Desloovere K, De Cat J, et al. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences. Eur J Neurol 2001; 8(Suppl. 5): 88-97.
5. Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11: 67-79.
6. Bjornson K, Hays R, Graubert C, et al. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. Pediatrics 2007; 120: 49-58.
7. Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics 2007; 119: e1149-58.
8. Russman BS, Tilton A, Gormley ME, Jr. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve 1997; 6(Suppl.): S181-93.
9. Heinen F, Schroeder AS, Fietzek U, Berweck S. When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy. Mov Disord 2006; 21: 2029-30.
10. Boyd RN, Britton TC, Robinson RO, Borzyskowski M. Transient urinary incontinence after botulinum A toxin. Lancet 1996; 348: 481-2.
11. Boyd RN, Graham JEA, Nattrass GR, Graham HK. Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur J Neurol 1999; 6: s37-45.
12. Howell K, Selber P, Graham HK, Reddihough D. Botulinum neurotoxin A: an unusual systemic effect. J Paediatr Child Health 2007; 43: 499-501.
13. US Food and Drug Administration. FDA Notifies Public Adverse Reactions Linked to Botox Use; Ongoing safety review of Botox. Botox Cosmetic and Myobloc taking place. (accessed 2 August 2008).
14. US Food and Drug Administration. FDA's MedWatch Safety Alerts. (accessed 29 July 2009).
15. US Food and Drug Administration. (accessed 25 June 2009).
16. Brashear A. The botulinum toxins in the treatment of cervical dystonia. Semin Neurol 2001; 21: 85-90.
17. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990; 40: 277-80.
18. Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999; 246: 265-74.
19. Crowner BE, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clin Neuropharmacol 2007; 30: 310-13.
20. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-23.
21. Liptak GS, O'Donnell M, Conaway M, et al. Health status of children with moderate to severe cerebral palsy. Dev Med Child Neurol 2001; 43: 364-70.
22. Naidu K, Smith K, Sheedy M, Adair B, Yu X, Graham HK. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy. Dev Med Child Neurol 2010; 52: 139-44.
23. Scheinberg A, O'Flaherty S, Waugh M, Baxter A, Gurd K. Letters to the Editor. J Paediatr Child Health 2008; 44: 468.
24. Naumann M, Albanese A, Heinen F, Molaenars G, Reija M. Safety and efficacy of botulinum toxin type A following long-term use. Eur J Neurol 2006; 13: s35-40.
25. Kanagasundaram SA, Lane LJ, Cavalletto BP, Keneally JP, Cooper MG. Efficacy and safety of nitrous oxide in alleviating pain and anxiety during painful procedures. Arch Dis Child 2001; 84: 492-5.
26. Graham HK, Reddihough D. Letters to the Editor. J Paediatr Child Health 2008; 44: 469.
27. Heinen F, Molenaers G, Fairhurst C, et al. European consensus Table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2006; 10: 215-25.
28. ACPR Group. Report of the Australian cerebral palsy register. Sydney, Australia. Birth years 1993-2003. Sydney, Australia: ACPR Group, 2009; 33.